WO2008014510A3 - Crystalline form a of ibandronic acid and process for the preparation - Google Patents
Crystalline form a of ibandronic acid and process for the preparation Download PDFInfo
- Publication number
- WO2008014510A3 WO2008014510A3 PCT/US2007/074738 US2007074738W WO2008014510A3 WO 2008014510 A3 WO2008014510 A3 WO 2008014510A3 US 2007074738 W US2007074738 W US 2007074738W WO 2008014510 A3 WO2008014510 A3 WO 2008014510A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- crystalline form
- ibandronic acid
- ibandronic
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates crystalline Form A of Ibandronic acid having Formula (I) and a process for the preparation thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07813544A EP2046342A4 (en) | 2006-07-28 | 2007-07-30 | Crystalline form a of ibandronic acid and process for the preparation |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82063806P | 2006-07-28 | 2006-07-28 | |
| US60/820,638 | 2006-07-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2008014510A2 WO2008014510A2 (en) | 2008-01-31 |
| WO2008014510A3 true WO2008014510A3 (en) | 2008-11-20 |
Family
ID=38982427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2007/074738 Ceased WO2008014510A2 (en) | 2006-07-28 | 2007-07-30 | Crystalline form a of ibandronic acid and process for the preparation |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2046342A4 (en) |
| WO (1) | WO2008014510A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2316841A1 (en) * | 2007-04-19 | 2011-05-04 | Dr. Reddy's Laboratories Limited | Ibandronate sodium polymorphs |
| US20090099390A1 (en) * | 2007-09-24 | 2009-04-16 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of ibandronic acid and processes for the preparation thereof |
| EP2609101B1 (en) * | 2010-07-14 | 2015-01-28 | Pharmathen S.A. | Process for the preparation of 3-(n-methyl-n-pentyl)amino-1-hydroxypropane-1,1-diphosphonic acid salt or derivatives thereof |
| TR201200588A2 (en) * | 2012-01-18 | 2012-07-23 | Koçak Farma İlaç Ve Ki̇mya Sanayi̇ Anoni̇m Şi̇rketi̇ | Processes for preparing sodium ibandronate monohydrate polymorphs and mixtures with polymorphs. |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006002348A2 (en) * | 2004-06-23 | 2006-01-05 | Teva Pharmaceutical Industies Ltd. | Solid and crystalline ibandronic acid |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004032577D1 (en) * | 2003-12-23 | 2011-06-16 | Alchymars S P A | Amorphous form the sodium salt of ibandronic acid |
| JP4559431B2 (en) * | 2004-08-23 | 2010-10-06 | テバ ファーマシューティカル インダストリーズ リミティド | Solid and crystalline ibandronate sodium and process for its preparation |
| US7214818B2 (en) * | 2004-10-29 | 2007-05-08 | Hoffmann-La Roche Inc. | Method for synthesizing bisphosphonate |
| WO2007074475A2 (en) * | 2005-12-27 | 2007-07-05 | Natco Pharma Limited | Novel polymorphic forms of ibandronate |
-
2007
- 2007-07-30 EP EP07813544A patent/EP2046342A4/en not_active Withdrawn
- 2007-07-30 WO PCT/US2007/074738 patent/WO2008014510A2/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006002348A2 (en) * | 2004-06-23 | 2006-01-05 | Teva Pharmaceutical Industies Ltd. | Solid and crystalline ibandronic acid |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP2046342A4 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008014510A2 (en) | 2008-01-31 |
| EP2046342A2 (en) | 2009-04-15 |
| EP2046342A4 (en) | 2011-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2460797A3 (en) | Process for preparation of ivabradine hydrochloride | |
| WO2009084024A3 (en) | A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof | |
| WO2009076142A3 (en) | Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids | |
| WO2008155615A3 (en) | An improved process for the preparation of cephalosporin antibiotic | |
| WO2009025876A8 (en) | Crystalline forms of erlotinib hcl and formulations thereof | |
| WO2006024024A3 (en) | Solid and crystalline ibandronate sodium and processes for preparation thereof | |
| WO2009083940A3 (en) | Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts | |
| WO2008058118A3 (en) | Preparation of montelukast and its salts | |
| WO2008021342A3 (en) | Amorphous and crystalline forms of 9-hydroxy-risperidone ( paliperidone ) | |
| WO2006127893A3 (en) | Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids | |
| WO2008083130A3 (en) | Amorphous and crystalline form a of carvedilol phosphate | |
| ZA200804171B (en) | Chemical process for the preparation of an amidophenoxybenzoic acid compound | |
| WO2008053334A3 (en) | An improved process for preparing rosuvastatin calcium | |
| WO2009100275A3 (en) | Compositions and devices | |
| WO2010008735A3 (en) | Solid states of o-desmethylvenlaf axine salts | |
| WO2008111096A3 (en) | Novel prodrugs | |
| WO2007098273A3 (en) | Novel crystalline forms of armodafinil and preparation thereof | |
| ZA201107412B (en) | Methods for the preparation of [2-8,9-dioxo2,6-diazabicyclo[5.2.0]non-1(1)-en-2-yl)ethyl]phosphonic acid and precursors thereof | |
| ZA200809171B (en) | Process for the preparation of pyrazolylaminoquinazoline derivatives comprising a phosphate group | |
| WO2007125521A3 (en) | Polymorphic form of zoledronic acid and processes for their preparation | |
| WO2010015656A3 (en) | Alkoxypyrazoles and the process for their preparation | |
| WO2008049922A3 (en) | A new process for the preparation of montelukast | |
| WO2008081268A3 (en) | Pharmaceutical compositions of entacapone | |
| WO2008014510A3 (en) | Crystalline form a of ibandronic acid and process for the preparation | |
| WO2007023342A3 (en) | Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07813544 Country of ref document: EP Kind code of ref document: A2 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 466/CHENP/2009 Country of ref document: IN |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2007813544 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |